X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (284) 284
Patent (34) 34
Publication (32) 32
Conference Proceeding (5) 5
Book Chapter (4) 4
Book / eBook (3) 3
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143) 143
oncology (66) 66
index medicus (64) 64
female (57) 57
male (52) 52
middle aged (51) 51
aged (49) 49
adult (44) 44
immunology (39) 39
immunotherapy (35) 35
animals (32) 32
cancer (29) 29
peptides (29) 29
chemistry (26) 26
expression (23) 23
mechanical engineering (23) 23
treatment outcome (23) 23
human necessities (22) 22
hygiene (22) 22
medical or veterinary science (22) 22
metallurgy (22) 22
organic chemistry (22) 22
preparations for medical, dental, or toilet purposes (22) 22
brain neoplasms - pathology (21) 21
cd8-positive t-lymphocytes - immunology (21) 21
multidisciplinary sciences (21) 21
brain neoplasms - immunology (20) 20
glioma (20) 20
glioblastoma (19) 19
lymphocytes (19) 19
mice (19) 19
tumors (19) 19
central-nervous-system (18) 18
chemotherapy (18) 18
sciences of the universe (17) 17
aged, 80 and over (16) 16
antigen (16) 16
biochemistry (16) 16
brain neoplasms - therapy (16) 16
t-lymphocytes - immunology (16) 16
therapy (16) 16
general tagging of cross-sectional technologies spanning over several sections of the ipc (15) 15
general tagging of new technological developments (15) 15
mars (15) 15
molecular sequence data (15) 15
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (15) 15
technologies or applications for mitigation or adaptation againstclimate change (15) 15
brain (14) 14
clinical neurology (14) 14
earth sciences (14) 14
identification (14) 14
in-vivo (14) 14
melanoma - immunology (14) 14
antigens, neoplasm - immunology (13) 13
beer (13) 13
compositions thereof (13) 13
culture media (13) 13
enzymology (13) 13
microbiology (13) 13
microorganisms or enzymes (13) 13
mutation or genetic engineering (13) 13
propagating, preserving or maintaining microorganisms (13) 13
receptors, antigen, t-cell, alpha-beta - genetics (13) 13
spirits (13) 13
vinegar (13) 13
wine (13) 13
amino acid sequence (12) 12
blasting (12) 12
brain neoplasms - drug therapy (12) 12
brain tumors (12) 12
cell line, tumor (12) 12
climate change mitigation technologies related totransportation (12) 12
combustion engines (12) 12
controlling combustion engines (12) 12
dendritic cells (12) 12
heating (12) 12
hot-gas or combustion-product engine plants (12) 12
lighting (12) 12
melanoma (12) 12
neoplasm proteins - immunology (12) 12
starting aids for such engines, not otherwise providedfor (12) 12
starting of combustion engines (12) 12
weapons (12) 12
aerospace engineering (11) 11
antineoplastic agents - therapeutic use (11) 11
atmosfärsvetenskap (11) 11
atmospheric science (11) 11
dacarbazine - analogs & derivatives (11) 11
engineering and technology (11) 11
maskinteknik (11) 11
medicine, research & experimental (11) 11
neurosciences (11) 11
rymd- och flygteknik (11) 11
t-lymphocytes, cytotoxic - immunology (11) 11
teknik och teknologier (11) 11
cancer vaccines - immunology (10) 10
clone cells (10) 10
combined modality therapy (10) 10
flow cytometry (10) 10
glioma - immunology (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e21061 - e21061
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 11/2019, Volume 31, Issue 6, pp. 514 - 521
PURPOSE OF REVIEWImmunotherapy is viewed as a promising approach for glioblastoma and, in particular, therapeutic vaccines are being intensively studied. Here,... 
Cancer vaccines | Usage | Drug therapy | Glioblastoma multiforme | Immunotherapy | Testing
Journal Article
Revue Medicale Suisse, ISSN 1660-9379, 05/2019, Volume 15, Issue 651, pp. 999 - 1000
Journal Article
Revue Medicale Suisse, ISSN 1660-9379, 05/2018, Volume 14, Issue 607, pp. 1011 - 1012
Journal Article
Revue medicale suisse, ISSN 1660-9379, 04/2016, Volume 12, Issue 516, p. 828
Glioblastomas are highly aggressive tumors. Their prognosis remain poor despite standard therapies combining surgery, radiation and temozolomide based... 
Glioblastoma - therapy | Immunotherapy - methods | Prognosis | Glioblastoma - pathology | Humans | Brain Neoplasms - pathology | Brain Neoplasms - therapy
Journal Article
Revue Medicale Suisse, ISSN 1660-9379, 04/2016, Volume 12, Issue 516, pp. 828 - 831
Journal Article
Revue Medicale Suisse, ISSN 1660-9379, 03/2018, Volume 14, Issue 598, pp. 555 - 556
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2018, Volume 36, Issue 34, pp. 3431 - 3431
Journal Article
Revue Medicale Suisse, ISSN 1660-9379, 05/2017, Volume 13, Issue 563, p. 1027
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2018, Volume 24, Issue 3, pp. 535 - 540
Glioblastoma is an aggressive malignancy with a poor prognosis. The current standard of care for newly diagnosed glioblastoma patients includes surgery to the... 
Brain | Trafficking | Glioblastoma | Central nervous system | Clinical trials | Lymphocytes T | Malignancy | Radiation therapy | ErbB-2 protein | Immunosuppression | Glioma | Lymphocytes | Medical prognosis | Surgery | Interleukin 1 | Temozolomide | Cancer
Journal Article
CNS oncology, 01/2014, Volume 3, Issue 1, p. 27
Pierre-Yves Dietrich is a Full Professor of Medicine at the University of Geneva (Geneva, Switzerland) and Director of the Centre of Oncology in the Geneva... 
Cancer Vaccines - therapeutic use | Immunotherapy - methods | Brain Neoplasms - immunology | Humans | Immunotherapy - trends | Vaccination | Brain Neoplasms - drug therapy
Journal Article
CNS Oncology, ISSN 2045-0907, 01/2014, Volume 3, Issue 1, pp. 27 - 29
Pierre-Yves Dietrich is a Full Professor of Medicine at the University of Geneva (Geneva, Switzerland) and Director of the Centre of Oncology in the Geneva... 
Views
Journal Article
Nature Medicine, ISSN 1078-8956, 08/2012, Volume 18, Issue 8, pp. 1254 - 1261
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs) confirmed to be naturally... 
MEDICINE, RESEARCH & EXPERIMENTAL | PULSED DENDRITIC CELLS | COLONY-STIMULATING FACTOR | HIGH-FREQUENCIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | MELANOMA PATIENTS | RENAL-CELL CARCINOMA | TUMOR-ANTIGEN | CELL BIOLOGY | MYELOID SUPPRESSOR-CELLS | PROSTATE-CANCER | REGULATORY T-CELLS | PEPTIDE VACCINE | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Prognosis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Kidney Neoplasms - immunology | Immunotherapy, Active | Male | Lymphocyte Depletion | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Carcinoma, Renal Cell - immunology | Cyclophosphamide - therapeutic use | Kidney Neoplasms - blood | T-Lymphocytes, Regulatory - immunology | Cancer Vaccines - therapeutic use | Vaccines, Subunit - therapeutic use | Female | Carcinoma, Renal Cell - drug therapy | Immunosuppressive Agents - pharmacology | Chemokine CCL17 - blood | Immunosuppressive Agents - administration & dosage | Kidney Neoplasms - therapy | Carcinoma, Renal Cell - blood | HLA-A2 Antigen - immunology | Antigens, Neoplasm - immunology | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | T-Lymphocytes, Regulatory - drug effects | Cyclophosphamide - pharmacology | Biomarkers | Carcinoma, Renal Cell - therapy | CD8-Positive T-Lymphocytes - immunology | Kidney Neoplasms - drug therapy | Apolipoprotein A-I - blood | Cancer vaccines | Cyclophosphamide | Polypeptides | Immune response | Dosage and administration | Research | Health aspects | Kidney diseases | Peptides | Gene expression | Medical prognosis | Cancer | Immune system
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 05/2017, Volume 104, Issue 5, pp. 476 - 484
Immunotherapy has proven efficient for many tumors and is now part of standard of care in many indications. What is the picture for brain tumors? The recent... 
Glioma | Immunotherapy | Microenvironment
Journal Article
by Weller, Michael and Butowski, Nicholas and Tran, David D and Recht, Lawrence and Recht, Lawrence D and Lim, Michael and Hirte, Hal and Ashby, Lynn and Mechtler, Laszlo and Goldlust, Samuel and Goldlust, Samuel A and Iwamoto, Fabio and Drappatz, Jan and O'Rourke, James and O'Rourke, Donald M and Wong, Mark and Hamilton, Mark G and Hamilton, Mark and Finocchiaro, Gaetano and Perry, James and Wick, Wolfgang and Green, Jennifer and He, Yi and Turner, Christopher D and Yellin, Michael J and Keler, Tibor and Davis, Thomas A and Stupp, Roger and Sampson, John H and Campian, Jian and Becker, Kevin and Barnett, Gene and Nicholas, Garth and Desjardins, Annick and Benkers, Tara and Wagle, Naveed and Groves, Morris and Kesari, Santosh and Horvath, Zsolt and Merrell, Ryan and Curry, Richard and Schuster, David and Mrugala, Maciej and Jensen, Randy and Trusheim, John and Lesser, Glenn and Belanger, Karl and Sloan, Andrew and Purow, Benjamin and Fink, Karen and Raizer, Jeffrey and Schulder, Michael and Nair, Suresh and Peak, Scott and Brandes, Alba and Mohile, Nimish and Landolfi, Joseph and Olson, Jon and Jennens, Ross and DeSouza, Paul and Robinson, Bridget and Crittenden, Marka and Shih, Kent and Flowers, Alexandra and Ong, Shirley and Connelly, Jennifer and Hadjipanayis, Costas and Giglio, Pierre and Mott, Frank and Mathieu, David and Lessard, Nathalie and Sepulveda, Sanchez Juan and Lövey, József and Wheeler, Helen and Inglis, Po-Ling and Hardie, Claire and Bota, Daniela and Lesniak, Maciej and Portnow, Jana and Frankel, Bruce and Junck, Larry and Thompson, Reid and Berk, Lawrence and McGhie, John and Macdonald, David and Saran, Frank and Soffietti, Riccardo and Blumenthal, Deborah and André de, Sá Barreto Costa Marcos and Nowak, Anna and Singhal, Nimit and Hottinger, Andreas and Schmid, Andrea and Srkalovic, Gordan and Baskin, David and Fadul, Camilo and Nabors, Louis and LaRocca, Renato and Villano, John and Paleologos, Nina and ... and ACT IV Trial Investigators and ACT IV trial investigators
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1373 - 1385
Rindopepimut (also known as CDX-110), a vaccine targeting the deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet... 
GLIOMAS | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | GROWTH-FACTOR | RADIOTHERAPY | CANCER | PEPTIDE | ADJUVANT TEMOZOLOMIDE | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | ErbB Receptors - genetics | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Dose-Response Relationship, Drug | Young Adult | Glioblastoma - genetics | Time Factors | Dacarbazine - analogs & derivatives | Adult | Female | Vaccines, Subunit - adverse effects | Brain Neoplasms - mortality | Dacarbazine - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Cancer Vaccines - adverse effects | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Internationality | Vaccines, Subunit - administration & dosage | Glioblastoma - pathology | Survival Analysis | Aged | Temozolomide | Glioblastoma - drug therapy | Glioblastoma - mortality | Antimitotic agents | Clinical trials | Care and treatment | Product development | Antineoplastic agents | Glioblastoma multiforme | Analysis
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2008, Volume 26, Issue 18, pp. 3015 - 3024
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 10/2018, p. JCO1800461
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.